glaxo may make $2.5b on swine flu - bloomberg
Published 14 years ago • 125 plays • Length 0:21Download video MP4
Download video MP3
Similar videos
-
1:04
glaxo's h1n1 shot wins u.s. approval; adobe to cut jobs: video
-
0:54
glaxo antibody treatment works on omicron mutations in study
-
1:06
xbb.1.5 variant | covid-19 update with dr. nick gilpin
-
2:04
sanofi, glaxosmithkline reach $2.1 billion deal with u.s. to supply vaccine doses
-
0:58
bracewell minute | climate change, greenhouse gas emissions, natural gas | may 5, 2023
-
10:08
green hydrogen plant wunsiedel
-
8:28
scientists measure how quickly crucial antarctica glacier is melting
-
4:01
is microalgae the sustainable food of the future?
-
1:03
new type of swine flu is 'relatively common,' china says
-
2:37
new covid-19 variant fueling winter surge
-
2:32
covid-19: new ventilation measures at sgh to prevent spread of virus
-
3:00
singapore aims to halve its 2030 peak greenhouse gas emissions by 2050
-
5:02
a new endemic covid-19 norm
-
5:58
high glucosinolate mustard as a biofumigant in vegetable systems- part 2
-
0:31
measuring annual greenhouse gas emissions
-
9:21
xinyu huang - pathogenic and antibiotic resistant potentials in the hadal microbiome | s01 mvif2
-
2:52
secure adequate vaccine supply & study virus genome - moh press conf (22 jun 09)
-
31:02
harwellxps workshop - shaoliang guan
-
1:23
local firm biosyngen opens cell manufacturing facility for immunotherapy
-
8:19
climate researcher dr jan minx on global warming, greenhouse gas emissions
-
1:01:59
hydrogen for a low-carbon future
-
0:41
samsung biologics lands multi-million dollar deal with swiss-based pharmaceutical firm